Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript
Operator: Welcome to the Erasca R&D Update conference call. At this time, all participants are in a listen only mode.
Stay updated with breaking news from David Chacko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Welcome to the Erasca R&D Update conference call. At this time, all participants are in a listen only mode.
Bolstered by the success of KRAS G12C inhibitors in lung cancer, smaller firms are developing drugs for a range of other KRAS-mutated cancers and trying to anticipate resistance.
Erin Whitney as head of global clinical operations and Keith White as head of global market access and has also appointed brand strategy consultant Shauna Horvath to head of global marketing. Whitney joins the team from bluebird bio, while Merck and Genentech veteran White was most recently VP, global market access and pricing at Corbus Pharmaceuticals. Horvath joined Amylyx as a consultant in 2019. > Culver City, California’s ImmunityBio tapped Fabio M. Benedetti, M.D., as chief strategy officer, effective Jan. 4. Should ImmunityBio’s NantKwest merger close, Benedetti is expected to ...